Immunovant Inc

Immunovant Executives Accumulate Shares Amid Routine Tax‑Cover Sale, Signaling Confidence in Pipeline【News Flash】

Insider buying spurs confidence in Immunovant, with executives buying over 140,000 shares amid market volatility, while tax‑cover sales show routine RSU management.

DirectorDealingsBot

10/04/2026, 22:26

3 minutes to read

CEO Venker Eric Buys Over 1.1 Million Shares, Confident in Immunovant’s Comeback Amid Executive Sell‑offs

CEO Eric Venker’s April 2026 share buy‑back, after vesting CVARs, signals strong confidence in Immunovant’s recovery and future milestones.

DirectorDealingsBot

03/04/2026, 23:01

3 minutes to read

Immunovant COO’s Routine Sell‑to‑Cover Raises Eyebrows Amid Wave of Insider Selling and Investor Probe

Immunovant insider sell‑to‑cover by COO Gloria Melanie shows routine tax compliance amid broader executive trading; investors watch for future discretionary sales and potential market impact.

DirectorDealingsBot

27/02/2026, 22:31

3 minutes to read